Highland Capital Management LLC lowered its stake in MetLife, Inc. (NYSE:MET – Free Report) by 2.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,438 shares of the financial services provider’s stock after selling 1,090 shares during the quarter. Highland Capital Management LLC’s holdings in MetLife were worth $4,294,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC raised its stake in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its stake in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. bought a new stake in MetLife during the 3rd quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC bought a new stake in MetLife during the 4th quarter valued at approximately $32,000. Institutional investors own 94.99% of the company’s stock.
MetLife Price Performance
Shares of MetLife stock opened at $86.77 on Thursday. The stock has a market cap of $60.08 billion, a price-to-earnings ratio of 17.49, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a 50 day moving average price of $83.95 and a 200-day moving average price of $80.30. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on MET shares. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays raised their price target on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, January 6th. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target for the company. TD Cowen raised their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Finally, Wells Fargo & Company cut their price target on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $90.46.
Check Out Our Latest Report on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Insider Trades May Not Tell You What You Think
- As China Tightens Rare Earth Exports, These 3 Stocks Are in Focus
- Market Cap Calculator: How to Calculate Market Cap
- Rebuilding the Empire: Can Dollar General Rally in 2025?
- How to invest in marijuana stocks in 7 steps
- Coinbase Gains Momentum on App Store—What It Means for the Stock
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.